MedPath
FDA Approval

Fosinopril Sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
June 15, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fosinopril(20 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Preferred Pharmaceuticals, Inc.

Preferred Pharmaceuticals, Inc.

Preferred Pharmaceuticals, Inc.

791119022

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fosinopril Sodium

Product Details

NDC Product Code
68788-7717
Application Number
ANDA077222
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 15, 2023
Code: NW2RTH6T2NClass: ACTIBQuantity: 20 mg in 1 1
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98GClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath